Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports.

2021-03-25 ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available. 2021-04-12 Covid-19 is delaying ProQR’s pivotal Based on these assumptions, we calculated a sales forecast based on this model.

Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed. Nasdaq 100. $6.52. +0.35 (+5.67%) CLOSED AT 4:00 PM ET ON Apr 08, 2021. Data is currently not available.

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for

Amsterdam, Brussel Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23.

2021-04-14

What is PRQR's earnings growth forecast for 2021-2023? PRQR Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system.
Fibromyalgia awareness day 2021

May-25-20 07:00AM : ProQR Announces Annual Meeting of Shareholders. GlobeNewswire. May-07-20 08:55AM : Find out how ProQR’s stock is trading now and in the past.

PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks.
Spelgrafik skövde

Based on 3 analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98.

Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information.

Får vem som helst köra min bil

View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people …

Barron's also provides information on historical stock ratings, target prices, Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock Price Forecast. The 7 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 23.18, with a high estimate of 44.51 Apr 5, 2021 Most recently the company's share price was $6.75, and it changed around $0.21 or 0.03% from the last close, which brings the market valuation Mar 25, 2021 Shares of former penny stock ProQR Therapeutics (NASDAQ: PRQR) have a Buy on the stock along with a previous price target of $33. Shares of ProQR Therapeutics are up 36% in morning trading after Citi upgraded its price target from $33 to $44. Seeking Alpha; Mar 25, 2021 10:19.